You are viewing the site in preview mode
Skip to main content
| |
Odds ratio
|
P-value
|
|---|
|
Point Estimate
|
95% CI
|
|---|
|
Age (years)
|
1.013
|
(1.005, 1.022)
|
0.0022
|
|
Sex
|
0.772
|
(0.632, 0.943)
|
0.0111
|
|
Target organ damagea
|
0.870
|
(0.668, 1.133)
|
0.3005
|
|
Home sphygmomanometers at baseline
|
0.959
|
(0.759, 1.212)
|
0.7262
|
|
Baseline SBP
|
0.990
|
(0.983, 0.997)
|
0.0066
|
|
Baseline DBP
|
0.991
|
(0.981, 1.001)
|
0.0845
|
|
Dyslipidemiab
|
0.968
|
(0.749, 1.252)
|
0.8046
|
|
FBS ≥100 mg/dL
|
0.715
|
(0.550, 0.929)
|
0.0121
|
|
Central obesity (men ≥90 cm, women ≥80 cm)
|
1.237
|
(0.993, 1.542)
|
0.0578
|
|
Family history of cardiovascular disease (men < 55 years, women < 65 years)
|
1.436
|
(0.875, 2.357)
|
0.1519
|
|
Intervention vs. control
|
0.836
|
(0.694, 1.007)
|
0.0586
|
- SBP systolic blood pressure, DBP diastolic blood pressure, FBS fasting blood glucose, BMI body mass index, eGFR estimated glomerular filtration rate, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol
- aTarget organ damage was defined as a composite of 1) stroke, transient ischemic attack, or vascular dementia; 2) left ventricular hypertrophy, angina, myocardial infarction, or heart failure; 3) albuminuria (albumin level > 30 mg/g) or chronic kidney disease (eGFR < 60 mL/min/1.73 m2); 4) peripheral vascular disease (ankle-brachial index < 0.9), pulse wave velocity > 10 m/sec, intimal thickness of the carotid artery > 1.0 mm, or large artery disease; and 5) stage 3 or 4 hypertensive retinopathy
- bDyslipidemia was defined as total cholesterol level ≥ 230 mg/dL, LDL-C level ≥ 150 mg/dL, HDL-C level < 40 mg/dL, or triglyceride ≥200 mg/dL
